Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and EnthesitisArthritis Care and Research.  71:717-734. 2019
2019 Akkermansia muciniphila is permissive to arthritis in the K/BxN mouse model of arthritisGenes and Immunity.  20:158-166. 2019
2019 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated UveitisArthritis Care and Research2019
2019 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated UveitisArthritis and Rheumatology2019
2019 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and EnthesitisArthritis and Rheumatology2019
2019 Standardizing terminology and assessment for orofacial conditions in juvenile idiopathic arthritis: International, multidisciplinary consensus-based recommendationsJournal of Rheumatology.  46:518-522. 2019
2018 Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literaturePediatric Rheumatology.  16. 2018
2018 Pediatric ocular lichen planus and lichen planopilaris: One new case and a review of the literaturePediatric Dermatology.  35:859-863. 2018
2018 Risk factors for intraarticular heterotopic bone formation in the temporomandibular joint in Juvenile idiopathic arthritisJournal of Rheumatology.  45:1301-1307. 2018
2018 Juvenile Psoriatic Arthritis: A Report from the GRAPPA 2017 Annual MeetingJournal of Rheumatology -Supplement-.  94:11-16. 2018
2018 Pediatric rheumatology infusion center: Report on therapeutic protocols and infusions given over 4 Years with focus on adverse events over 1 YearPediatric Rheumatology.  16. 2018
2018 Adiposity in juvenile psoriatic arthritisJournal of Rheumatology.  45:411-418. 2018
2018 Age and fecal microbial strain-specific differences in patients with spondyloarthritisArthritis Research.  20. 2018
2018 Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: A comparative study of children with and without juvenile idiopathic arthritisPediatric Rheumatology.  16. 2018
2018 Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?Pediatric Rheumatology.  16. 2018
2017 Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibitionPLoS ONE.  12. 2017
2017 Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: A retrospective studyPediatric Rheumatology.  15. 2017
2017 Isolated arthritis of the temporomandibular joint as the initial manifestation of juvenile idiopathic arthritisJournal of Rheumatology.  44:1632-1635. 2017
2017 Association of Anti–3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis PatientsArthritis Care and Research.  69:1088-1094. 2017
2017 Biologic therapies for refractory juvenile dermatomyositis: Five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North AmericaPediatric Rheumatology.  15. 2017
2017 The juvenile psoriatic arthritis cohort in the CARRA registry: Clinical characteristics, classification, and outcomesJournal of Rheumatology.  44:342-351. 2017
2016 Fecal metabolomics in pediatric spondyloarthritis implicate decreased metabolic diversity and altered tryptophan metabolism as pathogenic factorsGenes and Immunity.  17:400-405. 2016
2016 The microbiota in pediatric rheumatic disease: Epiphenomenon or therapeutic target?Current Opinion in Rheumatology.  28:537-543. 2016
2016 Ustekinumab as a Therapeutic Option for Children with Refractory Enthesitis-Related ArthritisJCR: Journal of Clinical Rheumatology.  22:282-284. 2016
2016 Gut microbiota-host interactions and juvenile idiopathic arthritisPediatric Rheumatology.  14. 2016
2015 Magnetic resonance imaging findings following intraarticular infliximab therapy for refractory temporomandibular joint arthritis among children with juvenile idiopathic arthritisJournal of Rheumatology.  42:2155-2159. 2015
2015 Novel method to collect medication adverse events in juvenile arthritis: Results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance projectArthritis Care and Research.  67:529-537. 2015
2015 Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseasesJournal of Rheumatology.  42:541-546. 2015
2015 Systemic and intra-articular anti-inflammatory therapy of temporomandibular joint arthritis in children with juvenile idiopathic arthritisSeminars in Orthodontics.  21:125-133. 2015
2015 Temporomandibular joint arthritis in juvenile idiopathic arthritis: The last frontierInternational Journal of Clinical Rheumatology.  10:273-285. 2015
2014 Gut microbes, immunity, and spondyloarthritisClinical Immunology.  159:134-142. 2014
2014 Treatment of juvenile idiopathic arthritis: A revolution in carePediatric Rheumatology.  12. 2014
2014 Adding canakinumab to the childhood arthritis and rheumatology research alliance consensus treatment plans for systemic juvenile idiopathic arthritis: Comment on the article by DeWitt et alArthritis Care and Research.  66:1430-1431. 2014
2014 Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritisArthritis Research.  16:486. 2014
2014 Imaging of the temporomandibular joint in juvenile idiopathic arthritisArthritis Care and Research.  66:47-54. 2014
2013 Treatment of Juvenile Idiopathic Arthritis in the Biologic AgeRheumatic Disease Clinics of North America.  39:751-766. 2013
2013 High doses of infliximab in the management of juvenile idiopathic arthritisJournal of Rheumatology.  40:1749-1755. 2013
2013 Safety and efficacy of intra-articular infliximab therapy for treatment-resistant temporomandibular joint arthritis in children: A retrospective studyRheumatology.  52:554-559. 2013
2013 Shrinking lung syndrome as a manifestation of pleuritis: A new model based on pulmonary physiological studiesJournal of Rheumatology.  40:273-281. 2013
2012 Mechanisms involved in the p62-73 idiopeptide-modulated delay of lupus nephritis in SNF1 miceLupus.  21:1552-1564. 2012
2012 Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritisJournal of Rheumatology.  39:1880-1887. 2012
2012 Intra-articular corticosteroid injections to the temporomandibular joints are safe and appear to be effective therapy in children with juvenile idiopathic arthritisJournal of Oral and Maxillofacial Surgery.  70:1802-1807. 2012
2012 Consensus treatment plans for new-onset systemic juvenile idiopathic arthritisArthritis Care and Research.  64:1001-1010. 2012
2012 17β-Estradiol (E-2) administration to male (NZB × SWR)F 1 mice results in increased Id LNF 1-reactive memory T-lymphocytes and accelerated glomerulonephritisLupus.  21:288-301. 2012
2012 MR enterography to evaluate sub-clinical intestinal inflammation in children with spondyloarthritisPediatric Rheumatology.  10. 2012
2012 IgA transglutaminase levels in children with Juvenile Idiopathic Arthritis.Annals of paediatric rheumatology.  1:31-35. 2012
2011 Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritisJournal of Rheumatology.  38:2274-2275. 2011
2011 Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritisClinical and Experimental Rheumatology.  29:582-588. 2011
2011 Psoriatic juvenile idiopathic arthritis: A tale of two subgroupsCurrent Opinion in Rheumatology.  23:437-443. 2011
2011 Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritisClinical and Experimental Rheumatology.  29:322-330. 2011
2011 Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory courseClinical and Experimental Rheumatology.  29:736-742. 2011
2010 Validity of self-report of infections in a longitudinal cohort of patients with rheumatoid arthritis differs by source of report and infection severityJournal of Clinical Epidemiology.  63:1358-1362. 2010
2010 Spondyloarthritis in a pediatric population: Risk factors for sacroiliitisJournal of Rheumatology.  37:2402-2408. 2010
2009 TNFα inhibitors may improve asthma symptoms: A case series of 12 patients with rheumatoid arthritis and asthmaJCR: Journal of Clinical Rheumatology.  15:198-200. 2009
2008 Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiencesBiologics : Targets & Therapy.  2:229-252. 2008
2008 Comparison of Vancouver and International League of Associations for Rheumatology classification criteria for juvenile psoriatic arthritisArthritis Care and Research.  59:51-58. 2008
2007 Immunization with peptides derived from the idiotypic region of lupus-associated autoantibodies delays the development of lupus nephritis in the (SWR × NZB)F1 murine modelJournal of Autoimmunity.  29:30-37. 2007
2006 Patients with juvenile psoriatic arthritis comprise two distinct populationsArthritis and Rheumatism.  54:3564-3572. 2006
2006 Subpopulations within juvenile psoriatic arthritis: A review of the literatureClinical and Developmental Immunology.  13:377-380. 2006
2004 Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: A study from a Children's Hospital Emergency Department and Urgent Care CenterArchives of Pediatrics and Adolescent Medicine.  158:671-675. 2004
2004 Efficacy of losartan in the treatment of erythrocytosis in a young adult with CRF [2]Pediatric Nephrology.  19:120-121. 2004
2003 Pheochromocytoma unmasked by imipramine in an 8-year-old girlPediatric Emergency Care.  19:174-177. 2003
2002 Nephrolithiasis in a neonate with transient renal wasting of calcium and magnesiumPediatric Nephrology.  17:386-389. 2002
2002 Molecular identification of pathogenetic Id LN F 1+ autoantibody idiotypes derived from the (NZBxSWR)F 1 model for systemic lupus erythematosusJournal of Autoimmunity.  19:87-101. 2002
2000 Systemic lupus erythematosus - Messages from experimental modelsRheumatology.  39:18-27. 2000
1996 Circadian variations of urinary electrolyte concentrations in preterm and term infantsJournal of Pediatrics.  128:253-256. 1996

Chapter

Year Title Altmetric
2018 Inflammatory bowel disease.  251-274. 2018
2018 Juvenile idiopathic arthritis.  221-237. 2018
2018 Rheumatoid arthritis.  183-199. 2018
2018 The microbiome: Past, present, and future.  3-11. 2018
2018 The promise of personalized medicine.  465-474. 2018
2014 Juvenile Idiopathic Arthritis.  1950-1963. 2014
Extra-articular manifestations: inflammatory bowel disease

Education And Training

  • Doctor of Medicine, Syracuse University 2001
  • Doctor of Philosophy in Immunology, Syracuse University 2001
  • Bachelor of Arts in Molecular Biochemistry, Wesleyan University 1994
  • Long Island Jewish Medical Center, Internship 2002
  • Long Island Jewish Medical Center, Residency 2004
  • Children's Hospital Boston, Postdoctoral Fellowship 2007
  • Full Name

  • Matthew Stoll